Professor Peter Hillmen
Professor of Experimental Haematology and Honorary Consultant Haematologist at Leeds Teaching Hospitals NHS Trust
Professor Peter Hillmen talks about Minimal Residual Disease (MRD) and why MRD is an important predictor for response to treatment for CLL patients. He also discusses advances in the treatment of CLL and what the next 5 years might see.
This interview was recorded at the CLL Ireland Information Day 2018 held in Dublin, Ireland, on 5 May 2018.